In the course of our search for anticancer agents based on a novel anti-austerity strategy, we found that the 70% EtOH extract of the crude drug Andrographis Herba (aerial parts of Andrographis paniculata), used in Japanese Kampo medicines, killed PANC-1 human pancreatic cancer cells preferentially in nutrientdeprived medium (NDM). Phytochemical investigation of the 70% EtOH extract led to the isolation of 21 known compounds consisting of six labdane-type diterpenes (11, 15, 17-19, 21), six flavones (5, 7, 10, 12, 14, 20) , three flavanones (2, 6, 16), two sterols (3, 8), a fatty acid (1), a phthalate (4), a triterpene (9), and a monoterpene (13). Among them, 14-deoxy-11,12-didehydroandrographolide (17) displayed the most potent preferential cytotoxicity against PANC-1 and PSN-1 cells with PC 50 values of 10.0 M and 9.27 M, respectively. Microscopical observation, double staining with ethidium bromide (EB) and acridine orange (AO), and flow cytometry with propidium iodide/annexin V double staining indicated that 14-deoxy-11,12-didehydroandrographolide (17) triggered apoptosis-like cell death in NDM with an amino acids and/or serum-sensitive mode.
Cancer is a major public health problem throughout the world. Pancreatic cancer is a most aggressive form of cancer and has an exceptionally high global mortality rate, with an estimated 330,372 deaths worldwide in 2012, which ranks 7th as the most frequent cause of cancer death. Moreover, it has been estimated that the number of deaths from pancreatic cancer will reach 540,000 by 2030 [1] . Pancreatic cancer rapidly metastases and leads to the death of patients in a short period after diagnosis. Thus, the 5-year survival rate of patients with pancreatic cancer is one of the lowest. Though surgery is the only treatment that offers any prospect of potential cure, chemotherapy with 5-fluorouracil and gemcitabine is also used for palliative therapy of advanced pancreatic cancer. However, it is largely resistant to most known chemotherapeutic agents, including 5-fluorouracil and gemcitabine [2] . Therefore, effective chemotherapeutic agents that target pancreatic cancer are urgently needed.
Tumor cells, in general, proliferate very fast, and the demand for essential nutrients and oxygen is always high. The immediate environment of cancers that are increasing in size, however, often becomes heterogeneous and some regions of large cancers often possess micro environmental niches, which exhibit a significant gradient of critical metabolites, including oxygen, glucose, other nutrients, and growth factors [3] . Thus, many cancer cells obtain their critical metabolites by randomly recruiting new blood vessels, a phenomenon commonly known as angiogenesis, to survive under such severe conditions. However, human pancreatic cancer survives with an extremely poor blood supply and becomes more malignant [4] . The method by which pancreatic cancer survives is by obtaining a remarkable tolerance to extreme nutrient starvation [5] . Therefore, it has been hypothesized that eliminating the tolerance of cancer cells to nutrition starvation may allow a novel biochemical approach known as "anti-austerity" for cancer therapy [6, 7] .
In this regard, we previously conducted preliminary screening of 500 medicinal plants used in Japanese Kampo medicines and identified active constituents of Arctii Fructus (fruits of Arctium lappa) [8] , Angelicae Pubescentis Radix (root of Angelica pubescens) [9] , Pini Resina (resin of Pinus massoniana) [10] , and Notopterygii Rhizoma (rhizome and root of Notopterygium incisum or N. forbesii) [11] . Moreover, we also examined anti-austeritic constituents of medicinal plants used in Myanmar and the Democratic Republic of Congo and of propolis [12] . In addition, we examined anti-austeric activity of 24 medicinal plants used in Japanese Kampo medicines and found that the 70% EtOH extract from Andrographis Herba (aerial parts of Andrographis paniculata) displayed potent preferential cytotoxicity (PC 50 : 9.72 g/mL) against a human pancreatic cancer PANC-1 cell line in nutrientdeprived medium (NDM) [13, 14] . In a continuing study, we recently examined the constituents of Andrographis Herba. We herein report the active constituent, together with the in vitro preferential cytotoxicity.
The CHCl 3 -soluble fraction of a 70% EtOH extract of Andrographis Herba exhibited potent preferential cytotoxicity with a PC 50 value of 9.72 g/mL against human pancreatic cancer PANC-1 cells. Thus, the CHCl 3 -soluble fraction was subjected to a series of chromatographic separations, which led to the isolation of 21 compounds. Their structures were identified by analyses of spectroscopic data and comparison with literature data to be: stearic acid (1) [15] , pinostrobin (2) [16] , -sitosterol (3) [17] , bis(2ethylhexyl) phthalate (4) [18] , 5-hydroxy-6,7-dimethoxyflavone (5) [19] , pinocembrin (6) [20], ermanin (7) [21], ergosterol peroxide (8) [22] , oleanolic acid (9) [23] , 5,3′,4′-trihydroxy-7-methoxyflavone (10) [24] , andrograpanin (11) [25] , skullcapflavone I (12) [26] , loliolide (13) [27] , 5-hydroxy-7,8,2′,5′-tetramethoxyflavone (14) [28] [32] , andrographolide (19) [33] , apigenin (20) [34] , and 14-deoxyandrographolide (21) [35] (Figure 1 ). Among these compounds, compounds 2, 4, and 6 have been isolated for the first time from an Andrographis species.
All compounds were evaluated for their in vitro preferential cytotoxicity against human pancreatic cancer PANC-1 and PSN-1 cells, and compounds 8, 9, 11, 13, 14, 17, and 19 induced cell death in both cell lines in NDM in a concentration-dependent manner, but not in normal medium (DMEM) (Supplementary data figure S1). Among these compounds, only 14-deoxy-11,12didehydroandrographolide (17) had potent activity with PC 50 values of 10.0 M and 9.27 M against PANC-1 and PSN-1 cells, respectively, whereas the other six had only a mild potency (PC 50 34-85 M) ( Table 1 ). 14-Deoxy-11,12-dihydroandrographholide (17) showed the most potent activity, andrograpanin (11) and andrographolide (19) revealed mild activity, but the other labdane-type diterpenes (15, 18, 21) were inactive. These results would suggest the importance of the -butyrolactone moiety, as reported previously [36] . In the previous report, on the other hand, it was also shown that the C12-C13 double bond is responsible for the cytotoxic activity [36], but our results have revealed that the C11-C12 double bond, not the C13-C14, is important. This might indicate the difference in the cytotoxic mechanism. On the other hand, 5-hydroxy-7,8,2′,5′tetramethoxyflavone (14) exhibited mild activity against PANC-1 and PSN-1 cells with PC 50 values of 74.9 and 74.1 M, respectively, whereas skullcapflavone I (12), with the same substitution pattern on rings A and C, did not show cytotoxicity (PC 50 > 100 M). Thus, the substituents on ring B may contribute to the preferential cytotoxicity. Numerous anti-austerity agents have been reported, and key nutrient(s) were examined to determine the sensitivity of cancer cells to them under nutrient depletion conditions. Among the antiausterity agents reported, pyrvinium pamoate, kigamicin D, and arctigenin induced necrotic cell death when glucose was depleted [6] [7] [8] . Troglitazone inhibited the survival of PANC-1 cells and caused necrosis under glucose and serum deprivation [5] , whereas (+)-grandifloracin induced apoptosis under glucose or serum deprivation [37] . 1,6,8-Trihydroxy-2,3,4,5-tetramethoxyxanthone and 1,6-dihydroxy-2,3,4,5,8-pentamethoxyxanthone caused cytotoxicity under glucose or amino acids deprivation in the presence of serum [12] . LY294002 led to inhibition under amino acid deprivation and caused apoptosis, although the effect was more prominent in the presence of serum [5] . Different from these compounds, damnacanthal induced cell death under serum deprivation [12] . Interestingly, compound 17 inhibited survival of PANC-1 cells under deprivation of amino acids or serum ( Figure  3A) , whereas 17 caused cell death of PSN-1 under deprivation of serum ( Figure 3B ).
We examined the mechanism of cell death induced by 14-deoxy-11,12-didehydroandrographolide (17) in PANC-1 and PSN-1 cells using microscopical observation, double staining with ethidium bromide (EB) and acridine orange (AO) [38] , and flow cytometry with propidium iodide/annexin V double staining. Microscopic observation of the dying PANC-1 and PSN-1 cells treated with 17 at 6.25 or 12.5 M displayed membrane bleb, nuclear fragmentation, and chromatin condensation (Figure 4 ), which are typical apoptosis-like morphological changes.
EB/AO double-staining can identify the viable, apoptotic, and necrotic cells based on color and appearance: 1) live cells, green with intact nuclei; 2) early-apoptotic cells, green with condensed and fragmented chromatin; 3) late-apoptotic cells; 4) necrotic cells, reddish orange without structural abnormality [38] . As shown in Figure 5 , control PANC-1 and PSN-1 cells were alive and stained green, whereas cells treated with either 6.25 or 12.5 M 17 under nutrient starvation appear orange with condensed and/or fragmented chromatin ( Figure 5 ), indicating apoptosis-like cell death. Flow cytometry with propidium iodide/annexin V double staining showed that PANC-1 cells grown in NDM and treated with either 6.25 or 12.5 M 17 for 8 h displayed propidium iodidenegative/annexin V-positive staining at levels of 34% and 55%, respectively ( Figure 6A ), and these ratios were raised to 47% and 55% by 16 h treatment, which also indicated apoptosis-like cell death [39]. These results were replicated in PSN-1 cells treated with 17 under nutrient starvation ( Figure 6B ). These results clearly indicated that 14-deoxy-11,12didehydroandrographolide (17) induced apoptosis-like cell death to PANC-1 and PSN-1 cells under nutrient starvation. Recently, 14deoxy-11,12-didehydroandrographolide (17) has been reported to induce apoptotic cell death of human promonocytic leukemia THP-1 cells through reduction of endogenous reduced glutathione (GSH) content [40] . Thus, 17 might induce cell death to human pancreatic cancer PANC-1 and PSN-1 cells through the same mechanism. 1 H and 13 C NMR spectra were recorded using either a JEOL JNM-LA400 or Bruker Avance DMX 500 spectrometer with TMS (tetramethylsilane) as an internal standard. EIMS measurements were carried out on a JEOL JMS-GCmate II mass spectrometer. Medium-pressure liquid chromatography (MPLC) was performed using a Büchi Sepacore system (Büchi Labortechnik AG, Flawil, Switzerland). Silica gel 60 N (spherical, neutral, 40-50 m, Kanto Chemical Co., Inc., Tokyo, Japan) was used for column chromatography. Analytical and preparative thin-layer chromatography (TLC) was performed using Merck precoated silica gel 60 F254 plates (0.25 or 0.5 mm thickness, Merck KGaA, Darmstadt, Germany). Fraction 9 (51.8 mg) was subjected to reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (5:10:1) to give stearic acid (1, 9.8 mg) [15] , pinostrobin (2, 3.0 mg) [16] , -sitosterol (3, 11.0 mg) [17] , and bis(2-ethylhexyl) phthalate (4, 1.0 mg) [18] . Fraction 10 (15.6 mg) was subjected to reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (5:8:1) to give 5-hydroxy-6,7dimethoxyflavone (5, 1.8 mg) [19] . Fraction 11 (94.0 mg) was subjected to reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (5:5:1) to give pinocembrin (6, 2.5 mg) [20], ermanin (7, 2.4 mg) [21], ergosterol peroxide (8, 4.2 mg) [22] , oleanolic acid (9, 11.6 mg) [23] , and 5,3′,4′-trihydroxy-7-methoxyflavone (10, 1.6 mg) [24] . Fraction 12 (104 mg) was subjected to reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (5:5:1) to give andrograpanin (11, 1.3 mg) [25] , skullcapflavone I (12, 1.6 mg) [26] , and loliolide (13, 2.2 mg) [27] . Fraction 13 (102 mg) was separated by reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (3:3:1) to give 5,2′-dihydroxy-7,8-dimethoxyflavone (12, 8.0 mg) and 5-hydroxy-7,8,2′,5′-tetramethoxyflavone (14, 2.6 mg) [28] . Fraction 14 (54.2 mg), after normal-phase preparative TLC with benzene-acetone (95:5), gave 4 sub-fractions. Sub-fraction 14-1 (13.6 mg) was purified by recrystallization to give 3-oxo-entcleroda-8(17),11,13-trien-16,15-olide (15, 2.3 mg) [29] . Fraction 15 (126 mg) was subjected to normal-phase preparative TLC with benzene-CH 3 CN (95:5) to give 6 sub-fractions. Sub-fraction 15-1 (24.9 mg), by reversed-phase preparative TLC with MeOH-H 2 O (4:1), gave 5,7,8-trimethoxyflavanone (16, 8 .0 mg) [30] . Subfraction 15-2 (54.2 mg) was separated by reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (2:2:1) to give 14deoxy-11,12-didehydroandrographolide (17, 16.3 mg) [31] . Fraction 16 (250 mg) was subjected to normal-phase preparative TLC with benzene-CH 3 CN (95:5) to give 3 sub-fractions. Subfraction 16-1 (39.4 mg) was separated by reversed-phase preparative TLC with MeOH-H 2 O (3:1) to give isoandrographolide (18, 4.2 mg) [32] , and andrographolide (19, 18.8 mg) [33] . Subfraction 16-2 (72.2 mg) was separated by reversed-phase preparative TLC with MeOH-CH 3 CN-H 2 O (2:2:1) to give apigenin (20, 3.1 mg) [34] , and 14-deoxyandrographolide (21, 11.0 mg) [35] . Preferential cytotoxicity: Preferential cytotoxicity was determined as previously described [8] [9] [10] [11] [12] . In brief, either PANC-1 (2 × 10 4 cells/well) or PSN-1 cells (1.5 × 10 4 cells/well) were seeded in 96well plates (Corning Inc., Corning, NY, USA) and incubated in fresh DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The cells were washed with Dulbecco's phosphate-buffered saline (PBS, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) before the medium was replaced with either DMEM or NDM containing serial dilutions of the test samples. After 4, 8, 12, or 24 h of incubation, the cells were washed with PBS, and 100 L of DMEM containing 10% WST-8 cell counting kit solution (Dojindo Laboratories, Kumamoto, Japan) was added to the wells. After 2 h of incubation, the absorbance was measured at 450 nm. Cell viability was calculated from the mean values for 3 wells using the following equation: Cell viability (%) = [(Abs (test samples) − Abs (blank) )/(Abs (control) − Abs (blank) )] × 100. The preferential cytotoxicity was expressed as the concentration at which 50% of cells died preferentially in NDM (PC 50 ). (−)-Arctigenin (purity 97%; Enzo Life Sciences, NY, USA) and paclitaxel (purity 99.5%; LC Laboratories, MA, USA) were used as a positive and negative control, respectively.
Experimental

General experimental procedures:
Cells and culture conditions:
Morphological assessment of PANC-1 and PSN-1 cells: PANC-1
(1 × 10 4 cells/well) or PSN-1 cells (0.75 × 10 4 cells/well) were seeded in 96-well plates and incubated in DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The medium was replaced with NDM (100 L/well) with or without 6.25 or 12.5 M of 17. After 24 h incubation, cells were observed using a phase contrast microscope.
EB/AO double staining: EB/AO double staining was performed according to the procedure previously described [38] . In brief, either PANC-1 (1 × 10 4 cells/well) or PSN-1 cells (0.75 × 10 4 cells/well) were seeded in 96-well plates and incubated in DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The medium was replaced with NDM (100 L/well) with or without 17 (6.25 or 12.5 M). After 12 h of incubation, 10 L of EB/AO solution [100 g/mL EB (Sigma-Aldrich Inc.) and 100 g/mL AO (Wako Pure Chemical Industries, Ltd.) in PBS] were added to each well, and the cells were observed using a fluorescent microscope (Biozero BZ-8000, Keyence Corp., Osaka, Japan). Cells stained by EB were detected with excitation and emission at 560 nm and 630 nm, respectively, while cells stained by AO were detected with excitation and emission at 480 nm and 510 nm, respectively.
